Hirschtritt, Matthew E.
Walker, Matthew P.
Krystal, Andrew D.
Article History
Received: 17 December 2022
Accepted: 12 April 2023
First Online: 24 April 2023
Declarations
:
: N/A.
: N/A.
: MPW serves as an advisor to and has equity interest in Oura, Bryte, OneCare Media, and StimScience. ADK has been the recipient of research grant funding from Janssen Pharmaceuticals, Axsome Pharmaceutics, Attune, Harmony, Neurocrine Biosciences, Reveal Biosensors, The Ray and Dagmar Dolby Family Fund, and the National Institutes of Health; has consulted for Adare, Axsome Therapeutics, Big Health, Eisai, Evecxia, Ferring Pharmaceuticals, Galderma, Harmony Biosciences, Idorsia, Janssen Pharmaceuticals, Jazz Pharmaceuticals, Millenium Pharmaceuticals, Merck, Neurocrine Biosciences, Neurawell, Pernix, Otsuka Pharmaceuticals, Sage, Takeda, and Angelini; and has option ownership in Big Health and Neurawell. MEH has no financial conflicts to disclose.